The association strongly recommends Europe include low-dose CT in revised screening recommendations. Read more
Winship Cancer Institute announces preceptor opportunity. NICE recommends tepotinib for select patients. Read more
PROVIDER RESOURCES
MARIPOSA OS Data Confirms Improved Efficacy for Amivantamab Plus Lazertinib in the First Line for EGFR-mutated NSCLC
INDUSTRY SUPPORTED
COCOON’s Prophylactic Regimen Resulted in Decreased Incidence and Severity of Dermatologic-related Adverse Events
